Tillman Hartley LLC’s Eli Lilly LLY Stock Holding History

Tillman Hartley LLC’s Portfolio LLY Stock Details LLY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$411K	Sell	447 -259	-37%	-$263K	0.1%	63
2025 Q4	$759K	Buy	706 +79	+13%	+$75.5K	0.19%	54
2025 Q3	$478K	Sell	627 -68	-10%	-$50.6K	0.12%	62
2025 Q2	$542K	Buy	695 +93	+15%	+$72.3K	0.15%	61
2025 Q1	$497K	Hold	602	–	–	0.14%	53
2024 Q4	$465K	Sell	602 -16	-3%	-$13.2K	0.13%	55
2024 Q3	$548K	Hold	618	–	–	0.16%	48
2024 Q2	$560K	Hold	618	–	–	0.19%	48
2024 Q1	$481K	Hold	618	–	–	0.17%	47
2023 Q4	$360K	Hold	618	–	–	0.13%	54
2023 Q3	$332K	Hold	618	–	–	0.14%	53
2023 Q2	$290K	Buy	618 +35	+6%	+$14.7K	0.12%	63
2023 Q1	$200K	Hold	583	–	–	0.09%	75
2022 Q4	$213K	Buy	+583	New	+$207K	0.09%	73

Other funds holding LLY

Lilly Endowment Indiananapolis, Indiana $84.5B AUM 11.36% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

PNC Financial Services Group Pittsburgh, Pennsylvania $173B AUM 20.72% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Tillman Hartley LLC's LLY Position: Q1 2026 in Review

Tillman Hartley LLC reduced its Eli Lilly (LLY) stake by 37% in Q1 2026, selling an estimated $263K and leaving 447 shares worth $411K. The position accounts for 0.1% of the portfolio, ranked #63.

Tillman Hartley LLC first reported a position in LLY in Q4 2022 and has held it in 14 quarters since. The position peaked at $759K in Q4 2025. 4,353 funds tracked by Wall St. Rank hold LLY as of Q1 2026.

Tillman Hartley LLC held 447 shares of Eli Lilly worth $411K as of Q1 2026.
Tillman Hartley LLC sold 259 Eli Lilly shares in Q1 2026, an estimated $263K.
Eli Lilly made up 0.1% of Tillman Hartley LLC's portfolio in Q1 2026, its #63 holding.
Tillman Hartley LLC first reported a position in Eli Lilly in Q4 2022 and has held it in 14 quarters since.
Tillman Hartley LLC's Eli Lilly position peaked at $759K in Q4 2025.
4,353 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.

Based on Tillman Hartley LLC's 13F filing for Q1 2026, filed 8 May 2026.